Study to Explore Effectiveness of Sublingual Fentanyl Spray in Emergency Department Patients With Acute Pain

NCT02137525 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was never initiated

Conditions

Acute Pain

Interventions

DRUG: Morphine 6 mg
DRUG: Fentanyl 100 µg
DRUG: Fentanyl 200 µg
DRUG: Fentanyl 400 µg
DRUG: Placebo Sublingual Spray
DRUG: Intravenous Placebo

Sponsor

INSYS Therapeutics Inc